Colon cleansing efficacy and safety with 1 L Plenvu® versus 2 L CLICOOL® study
Not Applicable
Completed
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0005894
- Lead Sponsor
- Korea University Anam Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 360
Inclusion Criteria
Patients 18 to 80 years of age who had scheduled for colonoscopy and signed the written informed consent form.
Exclusion Criteria
1.diagnosed with colorectal cancer and inflammatory bowel disease (IBD)
2.has undergone a bowel resection
3.Pregnant or nursing woman
4.with severe renal failure (creatinine cleavage <30mL/min)
5.have undergone colon endoscopy within 6 months of consent date
6.participated in other clinical trials within 6 months of the consent date
7.Should not be included in this study for any reason of the PI’s judgement.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of the success rate of the total colon cleansing effect by BBPS
- Secondary Outcome Measures
Name Time Method Comparison of PDR by section (Right, Proximal, Left Colon);Comparison of ADR by section (Right, Proximal, Left Colon);Comparison of BBPS Cleanness Scores by Section (Right, Proximal, Left Colon);Comparison of the MPP (mean poly per patient);Comparison of the MAP(mean adenoma per patient );Interval Time between completion of secondary medication and start of colonoscopy;Comparison of patient's questionnaire items such as side effects after taking the drug, patient evaluation